Cite
HARVARD Citation
D'Haens, G. et al. (n.d.). P473 Corticosteroid-free clinical remission rates with guselkumab maintenance therapy in patients with moderately to severely active Crohn's disease: Week 48 analyses from the phase 2 GALAXI 1 study. Journal of Crohn's and colitis. pp. i601-i602. [Online].